Status:
RECRUITING
Pilates Versus Gyrotonic Expansion System on Chemotherapy Induced Peripheral Neuropathy and Fall Risk
Lead Sponsor:
MTI University
Conditions:
Neuropathy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and dose-limiting side effect of neurotoxic chemotherapy (ie, taxanes, vinca alkaloids, platinum, and bortezomib) that interferes with pat...
Detailed Description
Pilates can be an effective intervention to address patients received chemotherapy and the associated increased risk of falls. CIPN is a common side effect of certain chemotherapy drugs, characterized...
Eligibility Criteria
Inclusion
- Adults aged 18-65 years
- Diagnosed with CIPN
- Completed at least 3 cycles of chemotherapy
- Ability to provide informed consent
Exclusion
- Severe neuropathy requiring pharmacological intervention
- Concurrent participation in another physical therapy regimen
- Any medical condition contraindicating physical exercise.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 5 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07137078
Start Date
October 1 2025
End Date
January 5 2026
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of physical therapy ,Cairo University
Cairo, Egypt, 3753450